Novo Nordisk (NVO) Taps Anthropic AI to Develop Next-Generation Medicines
The Ozempic maker sees a need for speed when it comes to AI
The Ozempic maker sees a need for speed when it comes to AI
No BS check run yet — press ⚖ to extract this story's claims and verify them against independent sources.
The Ozempic maker sees a need for speed when it comes to AI